OXFORD BIOSCIENCE PARTNERS IV LP's Net Worth

$28.7 Million

Who is OXFORD BIOSCIENCE PARTNERS IV LP?

OXFORD BIOSCIENCE PARTNERS IV LP has an estimated net worth of $28.7 Million. This is based on reported shares across multiple companies, which include Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., ACADIA PHARMACEUTICALS INC, Solexa, Inc., IMCOR PHARMACEUTICAL CO, and SIRNA THERAPEUTICS INC.

SEC CIK

OXFORD BIOSCIENCE PARTNERS IV LP's CIK is 0001140484

Past Insider Trading and Trends

2004 was OXFORD BIOSCIENCE PARTNERS IV LP's most active year for acquiring shares with 13 total transactions. OXFORD BIOSCIENCE PARTNERS IV LP's most active month to acquire stocks was the month of September. 2003 was OXFORD BIOSCIENCE PARTNERS IV LP's most active year for disposing of shares, totalling 10 transactions. OXFORD BIOSCIENCE PARTNERS IV LP's most active month to dispose stocks was the month of October. 2004 saw OXFORD BIOSCIENCE PARTNERS IV LP paying a total of $19,728,792.30 for 26,530,784 shares, this is the most they've acquired in one year. In 2004 OXFORD BIOSCIENCE PARTNERS IV LP cashed out on 16,493,594.39 shares for a total of $9,418,612.04, their largest year based on trade value.